MGNX News

Latest breaking news and updates for MGNX stock.

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

ROCKVILLE, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the...

Are there any notable changes in the company's capital structure (e.g., share repurchases, debt issuance, equity financing) that could affect dilution or leverage? What is the impact of any recent regulatory approvals or setbacks on the company's risk profile? How might the reported sentiment score of 20 influence market perception and short‑term trading sentiment?

Earnings

10 days ago

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

ROCKVILLE, MD, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company developing innovative antibody-based therapeutics for the treatment o...

How does the market historically react to long‑standing CEO transitions in similar biotech companies? Is there any insider trading activity or option activity surrounding the announcement that could signal market sentiment? Will the board composition shift with the addition of Risser, and how could that influence governance risk assessments?

Management

11 days ago